INS and cancer: While we cover a broad range of mechanistic pathways linking obesity to gastrointestinal cancers, such as inflammation, insulin resistance, adipokine imbalance, microbiome alterations, bile acid dysregulation, and hypoxia, the strength and depth of evidence supporting each mechanism vary by cancer type.